In ₹ Crore except Per Share Latest Annual | BAJAJHCARE FY26 | THEMISMED FY26 | LINCOLN FY26 | WANBURY FY25 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 66.57× | 1100.00× | ◆ 14.51× | 25.82× | 25.82× +158% | |
| P/B | 2.09× | 3.05× | ◆ 1.68× | 13.30× | 3.05× -31% | |
| EV/EBITDA | 12.52× | 3334.88× | ◆ 10.75× | 12.55× | 12.55× -0% | |
| Market Cap | ₹1,116 Cr | ₹1,216 Cr | ₹1,275 Cr | ₹789 Cr | ₹1,216 Cr -8% | |
| Growth | ||||||
| Revenue CAGR 3Y | -3.18% | -1.15% | ◆ 9.56% | 5.46% | 5.46% -158% | |
| Revenue CAGR 5Y | — | 8.21% | — | ◆ 10.29% | 9.25% | |
| Net Income CAGR 3Y | -28.44% | -72.81% | ◆ 6.43% | -27.91% | -27.91% -2% | |
| Revenue YoY (latest Q) | 11.28% | -10.88% | 15.07% | ◆ 24.47% | 15.07% -25% | |
| Net Income YoY (latest Q) | 15.75% | 273.08% | 30.93% | ◆ 1200.41% | 273.08% -94% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 17.15% | 0.11% | 14.56% | 12.73% | 12.73% +35% | |
| Net Income Margin | 2.58% | 0.33% | ◆ 13.10% | 5.09% | 5.09% -49% | |
| Return on Common Equity | 2.96% | 0.29% | 11.60% | ◆ 51.51% | 11.60% -74% | |
| Return on Capital Employed | 12.80% | -2.30% | 10.67% | ◆ 26.33% | 10.67% +20% | |
| Return on Assets | 1.71% | 0.19% | ◆ 9.87% | 7.38% | 7.38% -77% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.44× | 0.25× | ◆ 0.01× | 2.92× | 0.25× +76% | |
| Interest Coverage | 3.48× | -0.93× | ◆ 82.12× | 1.71× | 1.71× +104% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹611 Cr | ₹342 Cr | ₹671 Cr | ₹600 Cr | ₹600 Cr +2% | |
| Net Income | ₹15.8 Cr | ₹1.1 Cr | ₹87.9 Cr | ₹30.5 Cr | ₹30.5 Cr -48% | |
| Total Assets | ₹923 Cr | ₹598 Cr | ₹890 Cr | ₹414 Cr | ₹598 Cr +54% | |
| EPS | ₹4.98 | ₹0.12 | ₹43.88 | ₹9.32 | ₹9.32 -47% | |
| Book Value per Share | ₹158.34 | ₹43.28 | ₹378.25 | ₹18.09 | ₹43.28 +266% | |